Journal list Promote Sponsor
verified SJR 1,007 · Q1 • database Scopus / SJR & Web of Science indexed
Cytotherapy
United States · Elsevier B.V.
workspace_premium Q1 — Cell Biology lock_open Open Access

Cytotherapy

Cytotherapy is a journal indexed in SJR in Cell Biology and Immunology with an H index of 109. It has a price of 2970 €. It has an SJR impact factor of 1,007 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,007.

Cytotherapy focuses its scope in these topics and keywords: cell, mesenchymal, stem, stromal, therapy, human, cells, developments, measure, compared, ...

ISSN: 1465-3249
Publisher: Elsevier B.V.
Category: Cell Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,007 Q1
H-index 109
Acceptance rate pie_chart
25% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.970 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,007

H-index

109

Docs (year)

169

Docs 3y

403

Total refs

8533

Cites 3y

1300

Citable 3y

390

Cites/Doc 2y

3.03

Ref/Doc

50.49

Immediate OA

2970 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

cGMP and cell processing

View more

What do you want to be when you grow up?

View more

FDA's new regulatory paradigms for in vitro diagnostic devices

View more

FDA-NCI Workshop on Tumor Vaccines

View more

Evaluation in vitro of the therapeutic effect of mesenchymal stem cell-conditioned medium on drug induced liver injury

View more

EBMT and ISHAGE-Europe create a foundation for inspection and accreditation in Europe

View more

Detection of Ag-specific T cells by flow cytometry

View more

Deadly serious details

View more

DC-based immunotherapy of B-cell malignancies

View more

Current good manufacturing practices: application to the processing of hematopoietic cell components

View more

Cryopreservation of cord blood after liquid storage

View more

Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells

View more
SHOW MORE ARTICLES

Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasma

View more

A great adventure in cell therapy

View more

Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice

View more

Cell processing practices in Argentina: report of a multicenter survey

View more

Cell density-dependent proliferation in frequently-fed peripheral blood mononuclear cell cultures

View more

CD34+ immunoselected cells for poor graft function following allogeneic BMT

View more

Are you feeling ablated?

View more

Application of flow cytometry in the assessment of lymphoid reconstitution following BM transplantation

View more

An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation

View more

Adrian P. Gee, PhD, Editor Laureate

View more

Adoptive T-cell therapy for CMV

View more

Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation

View more

FAQs